StockData
Absci Corp logo

Absci Corp (ABSI) stock

ABSINasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$8.18+0.60 (+7.92%)

Close on Nov 18, 2026Market cap $1.40BP/E –Yield –

Absci revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Absci's revenue for the twelve months ending Jun 30, 2026 was $1.56M, down 62.3% year over year. For fiscal 2025 it was $2.80M, down 38.2% from the year before. The highest annual figure on record is $5.75M in fiscal 2022.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.80M-38.2%
FY2024Dec 31, 2024$4.53M-20.7%
FY2023Dec 31, 2023$5.72M-0.5%
FY2022Dec 31, 2022$5.75M+20.2%
FY2021Dec 31, 2021$4.78M+0.0%
FY2020Dec 31, 2020$4.78M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$318.00K-46.4%
Q1 FY2026Mar 31, 2026$215.00K-81.8%
Q4 FY2025Dec 31, 2025$650.00K-2.3%
Q3 FY2025Sep 30, 2025$378.00K-77.8%
Q2 FY2025Jun 30, 2025$593.00K-53.3%
Q1 FY2025Mar 31, 2025$1.18M+31.3%
Q4 FY2024Dec 31, 2024$665.00K+96.7%
Q3 FY2024Sep 30, 2024$1.70M+128.6%
Q2 FY2024Jun 30, 2024$1.27M-62.3%
Q1 FY2024Mar 31, 2024$898.00K-29.2%
Q4 FY2023Dec 31, 2023$338.00K-78.3%
Q3 FY2023Sep 30, 2023$744.00K-68.6%
Q2 FY2023Jun 30, 2023$3.37M+236.0%
Q1 FY2023Mar 31, 2023$1.27M+54.9%
Q4 FY2022Dec 31, 2022$1.56M+7.2%
Q3 FY2022Sep 30, 2022$2.37M+53.9%
Q2 FY2022Jun 30, 2022$1.00M+37.6%
Q1 FY2022Mar 31, 2022$819.00K-23.0%
Q4 FY2021Dec 31, 2021$1.45M-46.8%
Q3 FY2021Sep 30, 2021$1.54M+68.0%
Q2 FY2021Jun 30, 2021$728.00K+29.1%
Q1 FY2021Mar 31, 2021$1.06M–
Q4 FY2020Dec 31, 2020$2.73M–
Q3 FY2020Sep 30, 2020$916.00K–
Q2 FY2020Jun 30, 2020$564.00K–

More Absci figures

See a number that looks wrong?